Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 45, 2013 - Issue 2
Submit an article Journal homepage
587
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

Leonardo CalzaFrom the Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, ItalyCorrespondence[email protected]
,
Filippo TrapaniFrom the Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
,
Caterina SalvadoriFrom the Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
,
Eleonora MagistrelliFrom the Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
,
Roberto ManfrediFrom the Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
,
Vincenzo ColangeliFrom the Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
,
Maria Assunta Di BariFrom the Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
,
Marco BorderiFrom the Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
&
Pierluigi VialeFrom the Department of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
 show all
Pages 147-154 | Received 18 Jun 2012, Accepted 11 Jul 2012, Published online: 19 Sep 2012

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zhengtong Lv, Yuan Chu & Yong Wang. (2015) HIV protease inhibitors: a review of molecular selectivity and toxicity. HIV/AIDS - Research and Palliative Care 7, pages 95-104.
Read now
Benjamin Young, Kathleen E. Squires, Karen Tashima, Keith Henry, Stefan Schneider, Anthony LaMarca, Henry H. Zhao, Lisa L. Ross & Mark S. Shaefer. (2015) Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine. HIV Clinical Trials 16:4, pages 125-129.
Read now

Articles from other publishers (31)

Pingjing Wen, Xianmin Ge, Yanwu Wang, Yun Ge, Guanghua Lan, Bin Li, Guangqiu Qin, Qiuying Zhu, Huanhuan Chen, Jinhui Zhu, Huiyan Qin, Hui Yang, Hailan Luo, Yuqiu Gao, Qin Meng, Liuhong Luo, Shuaifeng Liu, Xiuling Wu, Shanshan Li & Yueqin Deng. (2023) Short‐term toxicity assessment of combined use of zidovudine, lamivudine and lopinavir/ritonavir in vitro and in vivo. Basic & Clinical Pharmacology & Toxicology 133:1, pages 82-97.
Crossref
Kayla L. Frost, Solène Marie & Nathan J. Cherrington. (2022) Mechanistic basis of increased susceptibility to nephrotoxicants in chronic liver disease. Current Opinion in Toxicology 31, pages 100347.
Crossref
Elena Alvarez, Lucy Campbell, Willard Tinago, Alejandro Garcia-Leon, Ian Walsh, Jennifer J Brady, Keith Burling, Sebastian Noe, Marie F Neuville, Francois Jouret, Farid Jamshidian, Hiba Graham, Martin Rhee, Paddy W Mallon & Frank A Post. (2022) The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study. Antiviral Therapy 27:4, pages 135965352210948.
Crossref
Z Kemec & F Akgul. (2022) Relationship between acute kidney injury requiring renal replacement treatment and mortality in patients with COVID-19. Nigerian Journal of Clinical Practice 25:8, pages 1348.
Crossref
Lígia N de M Ribeiro & Belchiolina B Fonseca. (2020) The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic. Future Microbiology 15:16, pages 1571-1582.
Crossref
Panupong Hansrivijit, Chenchen Qian, Boonphiphop Boonpheng, Charat Thongprayoon, Saraschandra Vallabhajosyula, Wisit Cheungpasitporn & Nasrollah Ghahramani. (2023) Incidence of Acute Kidney Injury and Its Association with Mortality in Patients with Covid-19: A Meta-Analysis. Journal of Investigative Medicine 68:7, pages 1261-1270.
Crossref
Chandrashekhar Voshavar. (2019) Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges. Current Topics in Medicinal Chemistry 19:18, pages 1571-1598.
Crossref
Taklo Simeneh Yazie, Teferra Abula Orjino & Wondwossen Amogne Degu. (2019) Reduced Kidney Function in Tenofovir Disoproxil Fumarate Based Regimen and Associated Factors: A Hospital Based Prospective Observational Study in Ethiopian Patients. International Journal of Nephrology 2019, pages 1-9.
Crossref
Allyson N Hamlin, Joseph Tillotson & Namandjé N Bumpus. (2019) Genetic variation of kinases and activation of nucleotide analog reverse transcriptase inhibitor tenofovir. Pharmacogenomics 20:2, pages 105-111.
Crossref
Gerard Joseph Chu, Christopher Henderson, Louise Evans, Kenneth Howlin & Ari Murad. (2018) Chronic granulomatous interstitial nephritis and urothelial metaplasia associated with ritonavir-boosted atazanavir: a case study and literature review. Pathology 50:5, pages 565-568.
Crossref
Frank J. Palella, Xiuhong Li, Samir K. Gupta, Michelle M. Estrella, John P. Phair, Joseph B. Margolick, Roger Detels, Lawrence Kingsley & Lisa P. Jacobson. (2018) Long-term kidney function, proteinuria, and associated risks among HIV-infected and uninfected men. AIDS 32:10, pages 1247-1256.
Crossref
Torsak Bunupuradah, Tanit Phupitakphol, Jiratchaya Sophonphan, Wasana Prasitsuebsai, Suvaporn Anugulruengkitt, Watsamon Jantarabenjakul, Bunruan Sopa, Kiat Ruxrungtham, Ankanee Chanakul & Thanyawee Puthanakit. (2018) Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents. Pediatric Infectious Disease Journal 37:1, pages 66-70.
Crossref
Maria Concetta Postorino, Mattia Prosperi, Emanuele Focà, Eugenia Quiros-Roldan, Elisa Di Filippo, Franco Maggiolo, Alberto Borghetti, Nicoletta Ladisa, Massimo Di Pietro, Andrea Gori, Laura Sighinolfi, Angelo Pan, Nicola Mazzini & Carlo Torti. (2017) Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort. BMC Infectious Diseases 17:1.
Crossref
M Biagi, ME Badowski, T Chiampas, J Young, M Patel & P Vaughn. (2016) Co-administration of elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine and atazanavir in treatment-experienced HIV patients. International Journal of STD & AIDS 28:8, pages 766-772.
Crossref
Q.F. Fernando Bernal. (2016) FARMACOLOGÍA DE LOS ANTIRRETROVIRALES. Revista Médica Clínica Las Condes 27:5, pages 682-697.
Crossref
James Milburn, Rachael Jones & Jeremy B. Levy. (2016) Renal effects of novel antiretroviral drugs. Nephrology Dialysis Transplantation, pages gfw064.
Crossref
Leonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, Marco Borderi, Matteo Conti, Rita Mancini & Pierluigi Viale. (2015) Improvement in Renal Function and Bone Mineral Density after a Switch from Tenofovir/Emtricitabine plus Ritonavir-Boosted Protease Inhibitor to Raltegravir plus Nevirapine: A Pilot Study. Antiviral Therapy 21:3, pages 217-224.
Crossref
Silvia A Guillemi, Sean H Ling, Julia S Dahlby, Benita Yip, Wendy Zhang, Mark W Hull, Viviane Dias Lima, Robert S Hogg, Ronald Werb, Julio S Montaner & Marianne Harris. (2016) Effects of a switch from tenofovir- to abacavir-based antiretroviral therapy, with or without atazanavir, on renal function. Journal of the International AIDS Society 19:1, pages 20995.
Crossref
J. Kubicka, J. Gizińska, J.D. Kowalska, E. Siwak, P. Swiecki, P. Pulik, B. Szulborska, E. Burkacka-Firlag & A. Horban. (2016) Efavirenz as component of initial combination antiretroviral therapy – Data from the Polish Observational Cohort of HIV/AIDS Patients (POLCA) Study Group. HIV & AIDS Review 15:2, pages 55-60.
Crossref
Ivete M. da Rocha, Aline S. Gasparotto, Rosmeri K. Lazzaretti, Regina K. Notti, Eduardo Sprinz & Vanessa S. Mattevi. (2015) Polymorphisms associated with renal adverse effects of antiretroviral therapy in a Southern Brazilian HIV cohort. Pharmacogenetics and Genomics 25:11, pages 541-547.
Crossref
Pedro Rodríguez Quesada, Laura López Esteban, Jimena Ramón García, Rocío Vázquez Sánchez, Teresa Molina García, Gabriel Gaspar Alonso-Vega & Javier Sánchez-Rubio Ferrández. (2015) Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients. International Journal of Clinical Pharmacy 37:5, pages 865-872.
Crossref
M. Hara, A. Suganuma, N. Yanagisawa, A. Imamura, T. Hishima & M. Ando. (2015) Atazanavir nephrotoxicity. Clinical Kidney Journal 8:2, pages 137-142.
Crossref
Lisa Hamzah, Lucy Campbell, Emily Wandolo, Birgit Engler, Emily Cheserem, Claire Naftalin, Chris Taylor & Frank A. Post. (2015) Changes in kidney function in patients with suppressed HIV RNA who substitute their protease inhibitor with atazanavir/ritonavir. AIDS 29:3, pages 392-394.
Crossref
P. Swiecki, J. Kubicka, J.D. Kowalska, P. Pulik, J. Gizinska, A. Ignatowska, G. Majkut, E. Firlag-Burkacka & A. Horban. (2015) Assessment of long-term safety and effectiveness of atazanavir (ATV) in the first antiretroviral treatment regimen in POLCA cohort. HIV & AIDS Review 14:2, pages 42-45.
Crossref
Darren M. Moss, Megan Neary & Andrew Owen. (2014) The role of drug transporters in the kidney: lessons from tenofovir. Frontiers in Pharmacology 5.
Crossref
E Cheserem, E Mabonga & FA Post. (2014) HIV and the kidney: a UK perspective. British Journal of Hospital Medicine 75:4, pages 197-201.
Crossref
Jean C. Yombi, Anton Pozniak, Marta Boffito, Rachael Jones, Saye Khoo, Jeremy Levy & Frank A. Post. (2014) Antiretrovirals and the kidney in current clinical practice. AIDS 28:5, pages 621-632.
Crossref
Leonardo Calza, Elisa Vanino, Eleonora Magistrelli, Caterina Salvadori, Alessandra Cascavilla, Vincenzo Colangeli, Maria Assunta Di Bari, Roberto Manfredi & Pierluigi Viale. (2013) Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. Clinical and Experimental Nephrology 18:1, pages 104-112.
Crossref
Ewa Siwak, Joanna Kubicka, Justyna D. Kowalska, Elżbieta Bąkowska, Paweł Święcki, Piotr Pulik, Ewa Pietraszkiewicz, Ewa Firląg-Burkacka & Andrzej Horban. (2014) Safety and effectiveness of lopinavir/ritonavir twice-daily in cART naïve patients with HIV-1 infection: Data from POLCA Study Group. HIV & AIDS Review 13:4, pages 120-124.
Crossref
Isobel D. Ramsay, Jodi M. Lestner, Catherine P. O’Sullivan, Ana L.G. Cruz, Ho Kwong Li & Charlotte I.S. Barker. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 401 443 .
D. M. Fine & J. E. Gallant. (2013) Nephrotoxicity of Antiretroviral Agents: Is the List Getting Longer?. Journal of Infectious Diseases 207:9, pages 1349-1351.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.